 |
|
|
| |
VIROLOGIC OUTCOMES BY RESISTANCE CATEGORY AND PRE-TREATMENT
IN THE DUALIS STUDY (dolutegravir+bDarunavir)
|
| |
| |
CROI2020
Reported by Jules Levin
Eva Wolf1, Christoph Boesecke2, Annamaria Balogh1, Helen Bidner3, Christiane Cordes4, Hans Heiken5, Ivanka Krznaric6, Tim Kummerle7, Jochen Schneider8, and Christoph D. Spinner8on behalf of the DUALIS STUDY GROUP
1MUC Research, Munich; 2Bonn University Hospital, Bonn 3Munich Study Center CRO; 4Private Practice, Berlin; 5Private Practice Georgstrasse, Hannover; 6Private Practice Center for Infectious Diseases Prenzlauer Berg, Berlin; 7Private Practice am Ebertplatz, Cologne, Germany; 8Technical University of Munich, School of Medicine, Munich, all Germany.
|
| |
|
|
|
|
|
